IDEXX (IDXX) CFO awarded new options and RSUs, reports tax share disposal
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
IDEXX Laboratories executive vice president, CFO and treasurer Andrew Emerson reported multiple equity compensation transactions. He exercised and converted several small lots of vested restricted stock units into common shares and had 123 shares of common stock disposed at $629.35 per share to cover tax obligations.
He also received new equity awards, including 4,270 non-qualified stock options and 162 incentive stock options, plus 729 and 284 restricted stock units. Footnotes state these options and RSUs vest in annual installments beginning on February 14, 2027, with some RSUs deferred under the company’s deferred compensation plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
456 shares exercised/converted
Mixed
15 txns
Insider
Emerson Andrew
Role
EVP, CFO and Treasurer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 61 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 94 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 42 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 194 | $0.00 | -- |
| Exercise | Common Stock | 61 | $0.00 | -- |
| Exercise | Common Stock | 94 | $0.00 | -- |
| Exercise | Common Stock | 42 | $0.00 | -- |
| Exercise | Common Stock | 194 | $0.00 | -- |
| Exercise | Common Stock | 65 | $0.00 | -- |
| Tax Withholding | Common Stock | 123 | $629.35 | $77K |
| Grant/Award | Non-Qualified Stock Option (right-to-buy) | 4,270 | $0.00 | -- |
| Grant/Award | Incentive Stock Option (right-to-buy) | 162 | $0.00 | -- |
| Grant/Award | Restricted Stock Unit | 729 | $0.00 | -- |
| Grant/Award | Restricted Stock Unit | 284 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 65 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Unit — 0 shares (Direct);
Common Stock — 3,950.444 shares (Direct);
Non-Qualified Stock Option (right-to-buy) — 4,270 shares (Direct);
Incentive Stock Option (right-to-buy) — 162 shares (Direct)
Footnotes (1)
- Includes a total of 18.666 shares purchased under the Issuer Employee Stock Purchase Plan on September 30, 2025 and December 31, 2025. Represents Restricted Stock Units ('RSU') that were granted on February 14, 2025, were deferred in accordance with the Issuer's Deferred Compensation Plan and have vested. Upon vesting, these RSUs were recorded in an account under such Plan and represents a contingent right to receive one share of Issuer common stock that is payable as soon as practicable after the reporting person's separation of service with the Issuer or a date specified by the reporting person. Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026. Includes 65 vested but deferred RSUs. Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027. Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030. Each RSU represents a contingent right to receive one share of Issuer common stock that vests in four annual installments, beginning February 14, 2027. Grant of RSUs that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in four annual installments, beginning February 14, 2027. Represents RSUs that were granted on February 14, 2025 and deferred in accordance with the Issuer's Deferred Compensation Plan and represents a contingent right to receive one share of Issuer common stock vesting in four annual installments, beginning February 14, 2026. Upon vesting, each such RSU will be recorded in an account under such Plan. Represents RSUs that were granted on February 14, 2025 and deferred in accordance with the Issuer's Deferred Compensation Plan and represents a contingent right to receive one share of Issuer common stock vesting in four annual installments, beginning February 14, 2026. Upon vesting, each such RSU will be recorded in an account under such Plan. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2024. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2026.
FAQ
What insider transactions did IDEXX (IDXX) CFO Andrew Emerson report?
Andrew Emerson reported option exercises, RSU conversions, and new equity grants. He converted several restricted stock units into common shares and received new stock options and RSU awards as part of his compensation, along with a small share disposition to satisfy tax withholding obligations.
How many stock options did the IDEXX (IDXX) CFO receive in this Form 4?
The CFO received 4,270 non-qualified and 162 incentive stock options. Footnotes explain these options to buy IDEXX common stock become exercisable in scheduled installments, beginning on February 14, 2027, with one option grant vesting fully on February 14, 2030.
What restricted stock units were granted to the IDEXX (IDXX) CFO?
He was granted 729 and 284 restricted stock units. Each RSU represents a contingent right to receive one IDEXX common share, vesting in four annual installments starting February 14, 2027, with some units deferred under the company’s deferred compensation plan after vesting.
How do the RSUs in the IDEXX (IDXX) Form 4 vest over time?
The RSUs generally vest in four annual installments. Footnotes state different RSU grants begin vesting on February 14 in various years, including 2024, 2025, 2026, and 2027, with some vested units deferred into the company’s deferred compensation plan.